IGM Biosciences Inc.: Navigating the Biotech Sector’s Volatility Amidst Cancer Treatment Challenges
IGM Biosciences Inc’s stock has experienced a dramatic rollercoaster ride, plummeting from a high of $22.50 to $1.13, raising questions about the company’s ability to deliver on its promises of revolutionizing cancer treatment.
3 minutes to read